Subtitle

Filtration solutions from Cytiva

Request a sample or support

9 - 12 September, 2024

Kistamässan Exhibition & Congress Centre Kista, Sweden

Request a sample or support

Subtitle

Process development and formulation services for pDNA
and mRNA

19 - 22 September, 2024

Kistamässan Exhibition & Congress Centre Kista, Sweden

Subtitle

Simplified tagged protein purification and tag removal

With Cytiva™ Protein Select™ resin and tag

Subtitle

Simplified tagged protein purification and tag removal

With Cytiva™ Protein Select™ resin and tag

12 September, 2024

Fill in the form to receive more information or a free consultation:

*Required
The Cytiva Difference

Collaborative relationship

We work closely with you, aligning goals and providing full transparency on scope, cost, and  progress throughout the project.

An extension of your team

We act as an extension of your team, bringing focused support, managing your project with the  ownership it deserves and training your team.

Proof of manufacturability

We support your molecule’s manufacturability with confidence—leveraging scalable equipment,  deep industry insight, and data-driven application notes.

From lab to launch—driven by your  goals, worldwide

The processes we develop are built for flexibility—enabling you to build, transfer, or collaborate  whenever and wherever it makes the most strategic sense.

Accelerate your development    timelines

Our integrated approach enables us to deliver on tight timelines, helping you reduce costs and  accelerate process development.



SUPRAdisc™ II depth filter modules

Next generation in depth filter module technology for bioprocess clarification applications.

The SUPRAdisc™ II module design combines the filtration performance of Seitz™ media and the structural robustness of interlocking dual drainage plates.

9 - 22 September, 2024

Kistamässan Exhibition & Congress Centre Kista, Sweden

Process development and formulation services for pDNA and mRNA

Applications

  • Process development and scale-up
  • Formulation screening and development
  • Analytical and bioassay services
  • Tech transfer and manufacturing
  • Contract development and manufacturing organization (CDMO) and biomanufacturing
  • Training and education
  • Project management
  • Quality support
  • Regulatory support

The future of mRNA manufacturing is rolling in

We’re bringing our KUBio box trailer mRNA facility to you.

ÄKTA go™ protein purification system

Compact liquid chromatography system to support routine protein purification in research laboratories.

The ELEVECTA™ cell line portfolio combines innovative design and deep expertise to deliver transient, packaging, and producer options that provide competitive performance, high quality, and flexibility.

  • Fit for purpose: Choose the option that makes sense for your stage, asset mix, and organizational goals.
  • Flexible: Enjoy competitive terms and the freedom to transition between cell lines as needs evolve.
  • Enhanced product quality*: Minimize host cell DNA inside capsids, which is resistant to nucleases.
  • Innovative: Access advances in cell line engineering informed by deep industry know-how.
  • Collaborative: We’re more than a supplier. Benefit from a comprehensive suite of regulatory support services designed to expedite your success in advancing to and through clinical trials.

Product specifications

ÄKTA go™ protein purification system

Throughput Up to 300 units per load / 1200 units per 8-hour shift
Pump type Peristaltic pump
Fill Volume Range 1.0 – 50 mL
In-process control Programmable up to 100% of units
Product contact materials Single-use flow path assembly
Interior classification ISO 5 / Grade A
Cleanroom classification ISO 8 / Grade D
Dimensions 1.7 x 1.5 x 2.2 m (5’6” x 4’9” x 7’2”)
Required cleanroom space 15m² (160 sq. ft.)
Electrical 208–240 VAC, single phase, 50–60 Hz, FLA 36

Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.

Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere.

Praesent lacus arcu, mollis ut volutpat pharetra, vulputate quis massa. Nam interdum fringilla bibendum.

Sed feugiat libero eu turpis tincidunt iaculis. In vel aliquam est, at porta neque. Donec hendrerit ultrices consectetur. Integer feugiat massa quis arcu ullamcorper, tristique facilisis massa feugiat. Phasellus risus mauris, pretium vitae tortor non, tristique fringilla tortor. Aliquam volutpat eros ac risus consectetur, quis gravida erat lobortis. Quisque id rutrum enim, sed fermentum nisl. Nulla volutpat turpis ac ligula venenatis maximus. In non dui ante.

Morbi faucibus sit amet dolor sit amet cursus. Quisque vulputate tellus in magna eleifend, ut luctus orci commodo.

Praesent tellus neque, maximus sit amet mauris in, fermentum pharetra ante. Sed sit amet nibh commodo, fringilla lectus ac, dictum velit. Aliquam cursus feugiat congue. Aenean sit amet enim massa. Praesent mollis sagittis est, ut accumsan eros lobortis id. Maecenas at libero ex. Proin quis est vitae tortor ullamcorper pretium eu non nunc. Quisque at lacus accumsan, finibus sapien ac, viverra ligula. Donec commodo bibendum elit sit amet posuere. Curabitur rutrum.

From concept to clinic: services for pDNA, mRNA, and LNPs

Our process development and formulation services from Cytiva help biotech companies accelerate their molecules through clinical development. With global reach and deep scientific expertise, we offer solutions and delivery technologies across plasmid DNA (pDNA), mRNA, and lipid nanoparticles (LNPs). Our experienced scientists will work closely with customers to set goals and manage their projects of any size with full transparency. We will support their molecule’s manufacturability, upskill their team with training and education, and transfer all process knowledge to them—until we cross the finish line together. Customers can think of us as an extension of their team.

Applications:


  • Process development and scale-up
  • Formulation screening and development
  • Analytical and bioassay services
  • Tech transfer and manufacturing
  • Contract development and manufacturing organization (CDMO) and biomanufacturing
  • Training and education
  • Project management
  • Quality support
  • Regulatory support

ELEVECTA™ transient cell line

Preseves flexibility while delivering excellent performance and quality - all aimed at quickly advancing candidates to clinical trials.

  • Excellent performance: Achieve high titers of infectious virus, which you can boost further by using enhancers.
  • Enhanced product quality*: Minimize DNase-resistant host cell DNA inside capsids.
  • Innovative: Access advances in cell line engineering across the entire portfolio to support transition between cell lines.
  • Collaborative: Benefit from a comprehensive suite of regulatory support services.

ELEVECTA™ packaging cell line

Contains all genes except the transgene; allows streamlining the screaning of assets that use the same capsid to target the same tissue type.

  • Streamlined screening: Efficiently screen multiple assets that target the same tissue type.
  • Cost-effective approach: Reduce your plasmid costs with single-plasmid transfection compared with triple transfection.
  • One cell line to clinic: Go to clinic with one cell line and simplify your regulatory asks when you’re targeting the same tissue type across your programs.

ELEVECTA™ producer cell line

Contains all genes to produce AAV; simply induce. The result is a simplified, robust, upstream process that easily scales to treat hundreds of thousands.

  • Simplified manufacturing process: Replace multi-step transfection with one-step induction.
  • Easy scalability: Scale up seamlessly to achieve large quantities of AAV material.
  • Enhanced reproducibility: Produce AAV from a monoclonal cell line, enabling batch-to-batch consistency.
  • Reduced COGS: Skip the need for transfection reagent and any plasmid DNA, which are the most expensive raw materials.

Qualitative standard filter paper [2 or 3 items]

Whatman Grade 3 Qualitative Filter Papers

A standard grade filter used in qualitative analytical techniques to determine and identify materials. For use in büchner funnels.

Whatman Grade 5 Qualitative Filter Papers

A standard grade clarifying filter excellent for cloudy suspensions and for water and soil analysis.

Whatman Grade 226 Qualitative Filter Papers

A general qualitative filter with creped surface. High filtration speed, faster than grade 202 and retain coarse particles gelatinous precipitates.

Outsource end-to-end manufacturing for pDNA and mRNA

Qualitative standard filter paper

Whatman Grade 114 Qualitative Filter Papers

Whatman Grade 1575 Qualitative Filter Papers

Whatman Grade 2 Qualitative Filter Papers

Outsource end-to-end manufacturing for pDNA and mRNA

Product Comparison

ÄKTA go™

ÄKTA go™

Achieve desired purity with ease in routine purifications – make the most of valuable bench/cold-room space

ÄKTA pure™

ÄKTA pure™

Flexibility in research – match most current and future purification challenges

ÄKTA start™

ÄKTA start™

Entry level chromatography solution for the preparative purification of proteins in lab scale.

ÄKTA oligosynt™

ÄKTA oligosynt™

Compact, fully automated oligonucleotide synthesizer to support research and process development laboratories.

Support for affinity chromatography, ion exchange chromatography, and multimodal (mixed mode) chromatography yes yes yes yes
Support for affinity chromatography, ion exchange chromatography, multimodal (mixed mode) and size exclusion chromatography yes yes no no
Support for hydrophobic interaction chromatography yes yes yes no
Scale up, method development and optimisation using design of experiment (DoE) no yes yes yes
Automated: resin/column scouting, multistep purification, external equipment no yes no yes
Wavelength (nm) Fixed at 280nm Optional Fixed at 280, dual 260/280 or multi – up to 3 between 190-700 Fixed at 280nm Optional Fixed at 280, dual 260/280 or multi – up to 3 between 190-700
Recommended flow rate (mL/min) 0.01-25.0 0.001-25/0.01-150 0.01-25.0 0.001-25/0.01-150
Maximum operating pressure (Mpa) 5 20/5 7 20/4

    Thank you for your interest! Here is your digital goodie bag from Cytiva.

    From posters and webinars to application notes and online learning, simply click on the links below to access some of our latest resources to support your cell and gene therapy advances.

    Agenda

    Agenda and schedules are subject to change. All times listed are in CEST.

    Monday, 3 February, 2025

    On the first day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.

    Time Details
    8:00 - 9:00 Registration
    9:10 - 10:40 Nestor Santiago and Gillian Goodwin Biacore™ system assay development revisited - Recipe for successful SPR data
    10:50 - 12:20 Cynthia Shuman and Eric Roush Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system
    12:30 - 14:30 Lunch break
    14:45 - 16:00 Christin Radon and Emeric Gueneau Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation
    16:10 - 16:40 Anja Drescher and Mike Murphy Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison
    16:50 - 17:20 John Sinfield and Shannon Bryan Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish

    Tuesday, 4 February, 2025

    On the second day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.

    Time Details
    7:00 - 8:30 Registration
    8:40 - 10:40 Nestor Santiago and Gillian Goodwin Biacore™ system assay development revisited - Recipe for successful SPR data
    10:50 - 12:20 Cynthia Shuman and Eric Roush Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system
    12:30 - 14:30 Lunch break
    14:45 - 16:00 Christin Radon and Emeric Gueneau Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation
    16:10 - 16:40 Anja Drescher and Mike Murphy Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison
    16:50 - 17:20 John Sinfield and Shannon Bryan Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish

    Wednesday, 5 February, 2025

    On the third day, we will welcome you all to Sweden at the site for a reception lunch. Have a bite to eat and chat with us and other attendees. Once fed and settled, we will commence the first workshops of the week. Simultaneously, a second group will be taken to the Cytiva Uppsala site to see where the magic happens.

    Time Details
    8:30 - 9:15 Registration
    9:25 - 10:40 Nestor Santiago and Gillian Goodwin Biacore™ system assay development revisited - Recipe for successful SPR data
    10:50 - 12:20 Cynthia Shuman and Eric Roush Slow and steady wins the race: Techniques for measuring slow dissociation rates using Biacore SPR system
    12:30 - 14:30 Lunch break
    14:45 - 16:00 Christin Radon and Emeric Gueneau Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation
    16:10 - 16:40 Anja Drescher and Mike Murphy Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison
    16:50 - 17:20 John Sinfield and Shannon Bryan Biacore™ Insight Software – A look beneath the surface: interesting facts and hidden features that will improve your workflows from start to finish

    Agenda single day

    Agenda and schedules are subject to change. All times listed are in CEST.

    Time Details
    8:30 - 9:00 Welcome and opening
    9:00 - 10:30 Stephan Poetsch ÄKTA™ chromatography systems family, system specifications and UNICORN with the new developments in the portfolio
    10:30 - 11:00 Break
    11:00 - 12:00 Stephan Poetsch ÄKTA™ basic care and troubleshooting - To prevent problems during protein purification
    12:00 - 13:30 Christin Radon and Emeric Gueneau Thinking outside 1:1 – Discover how to approach assay design for induced proximity and targeted protein degradation
    13:30 - 15:00 Anja Drescher and Mike Murphy Facilitating comparability with SPR-based surrogate potency assays and sensorgram comparison

    Cell therapy resources

    Regulatory: US preclinical study of cellular and gene therapies

    This free interactive course provides a high-level overview of preclinical study in cellular and gene therapy (CGT) development.

    Our location

    Testimonials